References
Bartram CR, Raghavachar A, Porzsolt F Immunoglobulin and T Cell Receptor Gene Rearrangements in Hairy Cell Leukemia (Submitted for Publication)
Bouroncle BA, Wiseman BK, Doan A (1958) Leukemic reticuloendotheliosis. Blood 13: 609–629
Bouroncle BA (1984) The History of Hairy Cell Leukemia: Characteristics of Long-Term Survivors. Semin Oncol 11 (Suppl 2): 479–485
Budd GT, Bukowski RM, Miketo L (1984) Phase I trial of Ultrapure IM human leukocyte interferon in human malignancy. Cancer Chemother Pharmacol 12: 39–42
Catovsky D, O'Brian M, Melo JV, Wardle J, Brozovic M (1984) Hairy cell leukemia (HCL) variant: An intermediate disease between HCL and B prolymphocytic leukemia. Semin Oncol 11 (Suppl 1): 362–369
Cawley JC, Burns GF, Hayhoe FGJ (1980) A chronic lymphoproliferative disorder with distinctive features: distinct variant of hairy cell leukemia. Leuk Res 4: 547–559
Dickson D (1982) Deaths halt interferon trials in France. Science 218: 772
Flandrin G, Sigaux F, Sebahoun G, Bouffette P (1984) Hairy Cell Leukemia: Clinical Presentation, Follow-Up of 211 Patients. Semin Oncol 11 (Suppl 2): 458–471
Gastl G, Aulitzky W, Leiter E, Flener R, Huber C (1986) Effect of interferon on LGL and NK activity in hairy cell leukemia. Blut 52: 273–279
Golomb HM, Vardiman J (1978) Hairy cell leukemia: diagnosis and management. Cancer J Clin 28: 265–277
Golomb HM (1984) Introduction to Hairy Cell Leukemia Part 2. Semin Oncol 11 (Suppl 2): 457
Hagberg H, Alm G, Björkholm M, Glimelius B, Killander A, Simonsson B, Sundström C, Ähre A (1985) Alpha interferon treatment of patients with hairy-cell leukaemia. Scand J Haematol 35: 66–70
Hersh EM, Quesada J, Keating MJ, Rasmussen S, Murphy SG, Gschwind C, Morgan J (1982) Host Defense Factors and Prognosis in Hairy Cell Leukemia. Leuk Res 6: 625–637
Jacobs AD, Naiem F, Champlin RE, Golde DW (1985) Toxicity and Bone Marrow Response of Patients with Hairy Cell Leukemia Treated with Biosynthetic (Recombinant) α-2-Interferon. Blut 50: 33–34
Jansen J, Hermans J (1981) For the collaborative study group: Splenectomy in Hairy Cell Leukemia: A Retrospective Multicenter Analysis. Cancer 47: 2066–2076
Jansen J, Hermans J (1982) Clinical Staging System for Hairy-Cell Leukemia. Blood 60: 571–577
Jansen J, den Ottolander GJ, Holdrinet RSG, Tricot GJK, Hermans J (1984) Prognosis and Therapy in Hairy Cell Leukemia. Semin Oncol 11 (Suppl 2): 472–478
Katayama I, Mochino T, Honma T, Fukuda, M (1984) Hairy Cell Leukemia: A Comparative Study of Japanese and Non-Japanese Patients. Semin Oncol 11 (Suppl 2): 486–492
Martino S, Samal BA, Sohn YH (1985) Reversible cardiac arrhythmia in a breast cancer patient treated with recombinant alpha interferon. Breast Cancer Res Treat 5: 327–329
Naeim F (1982) Clinicopathological Subtypes in Hairy-cell Leukemia. Am Soc Clin Pathol 78: 80–85
Porzsolt F, Thomä J, Unsöld M, Wolf W, Obert HJ, Kubanek B, Heimpel H (1985) Platelet-Adjusted IFN Dosage in the Treatment of Advanced Hairy Cell Leukemia. Blut 51: 73–82
Porzsolt F, Janik R, Heil G, Brudler O, Raghavachar A, Scholz S, Papendick U, Heimpel H (1986) Deficient IFN-α production in Hairy Cell Leukemia. Blut 52: 185–190
Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU (1984) Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 310: 15–18
Ratain MJ, Golomb HM, Vardiman JW, Vokes EE, Jacobs RH, Daly K (1985) Treatment of Hairy Cell Leukemia With Recombinant Alpha2 Interferon. Blood 65: 644–648
Rosenblum MG, Maxwell BL, Talpaz M, Kelleher PJ, Mccredie KB, Gutterman JU (1985) In vivo Sensitivity and Resistance of Chronic Myelogenous Leukemia Cells to Alpha Interferon: Correlation with Receptor Binding and Induction of 2', 5' Oligoadenylate Synthetase. ISIR meeting, Clearwater Beach (Abstract)
Ruco LP, Procopic A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD (1983) Severe deficiency of natural killer activity in peripheral blood of patients with hairy cell leukemia. Blood 61: 1132–1137
Ruco LP, Stoppacciaro A, Valtieri M, Procopio A, Uccini S, Baroni CD (1983) Hairy cell leukemia: absence of natural killer activity and of interleukin 1 release in OKM 1 spleen hairy cell. Clin Immunol Immunopathol 26: 47–55
Sarna G, Figlin R, Callaghan M (1983) (Human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: A phase II trial. J Biol Response Mod 2: 343–347
Thompson JA, Brady J, Kidd P, Fefer A (1985) Recombinant Alpha-2 Interferon in the Treatment of Hairy Cell Leukemia. Cancer Treat Rep 69: 791–793
Worman CP, Catovsky D, Bevan PC, Camba L, Joyner M, Green PJ, Williams HJH, Bottomley JM, Gordon-Smith EC, Cawley JC (1985) Interferon is effective in hairy-cell leukaemia. Br J Haematol 60: 759–763
Author information
Authors and Affiliations
Additional information
Supported by Deutsche Forschungsgemeinschaft SFB 112
Rights and permissions
About this article
Cite this article
Porzsolt, F. Primary treatment of hairy cell leukemia: Should IFN-therapy replace splenectomy?. Blut 52, 265–272 (1986). https://doi.org/10.1007/BF00320789
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320789